This document provides an overview of topics related to preparing narcotic compounded sterile preparations. It discusses the legal regulations for controlled substances, properties of narcotic CSPs, potential complications of parenteral therapy, storage and record keeping of controlled substances, guidelines for preparing patient-controlled analgesia, and USP Chapter <797> procedures. The objectives are to understand regulations and demonstrate proper technique for preparing narcotic CSPs.
This document discusses various calculations used in sterile compounding. It covers learning objectives, types of calculations including basic formula, ratio and proportion, dimensional analysis, IV flow rates, IV drip rates, and alligations. It provides examples of how to perform each type of calculation and notes the specific scenarios where each method is best used. The goal is for readers to understand the principles and practice calculations to determine the correct method based on the medication and sterile compounding procedure.
This document discusses the sterile compounding environment, including the setup and characteristics of anterooms and clean rooms. It describes the ISO classification levels for particulate matter in these areas and different types of hoods used for sterile compounding. USP Chapter <797> guidelines for hoods and the four risk levels for sterile compounding are also summarized.
Sterile Compounding as a Pharmacy Technician Kdurant36
The document provides an overview of sterile compounding and aseptic technique for pharmacy technicians. It discusses the historical roots of pharmacy and sterile compounding. It also outlines the key roles and responsibilities of pharmacy technicians in preparing sterile compounded preparations and defines important terms like aseptic technique. Maintaining aseptic technique is crucial for patient health and safety. The document reviews the training and certification requirements for pharmacy technicians set by organizations like USP and state boards of pharmacy.
This document provides an overview of small-volume parenteral (SVP) preparations, also known as intravenous piggybacks (IVPBs). It discusses the origins and uses of IVPBs, how they are compounded, potential complications, and United States Pharmacopeia (USP) Chapter <797> guidelines for sterile compounding. The document outlines learning objectives and topics to be covered, which include IVPB supplies, resources, compounding procedures using different techniques like milking or vented needles, and a preview of lab procedures. Superbugs and antibiotic-resistant bacteria are presented as growing health concerns with parental therapy.
This document provides an overview of pediatric compounding sterile preparations. It discusses how pediatric medicine considers the specific healthcare needs of children. Pediatric compounding involves preparing small volume sterile solutions and considering factors like pediatric dosing, formulations, administration routes, potential complications, and USP guidelines. The document outlines supplies and procedures for compounding a pediatric special dilution, including anteroom and clean room preparation steps.
Pulmonary drug delivery (PDD) systems were recently introduced into the pharmaceutical field to treat both the local and the systemic types of lung diseases. PDD systems are known to be able to simply deliver the drug to the required site in the body directly or to other distant sites through the bloodstream.
The document provides an overview of drug delivery to the respiratory system. It discusses the advantages of pulmonary drug delivery such as it being needle-free and requiring a low dose. It describes the different regions of the respiratory tract and various formulation approaches for drug delivery, including marketed products that use different devices like dry powder inhalers and metered dose inhalers. The document also mentions some patented preparations and recent advances in pulmonary drug delivery.
This document discusses various calculations used in sterile compounding. It covers learning objectives, types of calculations including basic formula, ratio and proportion, dimensional analysis, IV flow rates, IV drip rates, and alligations. It provides examples of how to perform each type of calculation and notes the specific scenarios where each method is best used. The goal is for readers to understand the principles and practice calculations to determine the correct method based on the medication and sterile compounding procedure.
This document discusses the sterile compounding environment, including the setup and characteristics of anterooms and clean rooms. It describes the ISO classification levels for particulate matter in these areas and different types of hoods used for sterile compounding. USP Chapter <797> guidelines for hoods and the four risk levels for sterile compounding are also summarized.
Sterile Compounding as a Pharmacy Technician Kdurant36
The document provides an overview of sterile compounding and aseptic technique for pharmacy technicians. It discusses the historical roots of pharmacy and sterile compounding. It also outlines the key roles and responsibilities of pharmacy technicians in preparing sterile compounded preparations and defines important terms like aseptic technique. Maintaining aseptic technique is crucial for patient health and safety. The document reviews the training and certification requirements for pharmacy technicians set by organizations like USP and state boards of pharmacy.
This document provides an overview of small-volume parenteral (SVP) preparations, also known as intravenous piggybacks (IVPBs). It discusses the origins and uses of IVPBs, how they are compounded, potential complications, and United States Pharmacopeia (USP) Chapter <797> guidelines for sterile compounding. The document outlines learning objectives and topics to be covered, which include IVPB supplies, resources, compounding procedures using different techniques like milking or vented needles, and a preview of lab procedures. Superbugs and antibiotic-resistant bacteria are presented as growing health concerns with parental therapy.
This document provides an overview of pediatric compounding sterile preparations. It discusses how pediatric medicine considers the specific healthcare needs of children. Pediatric compounding involves preparing small volume sterile solutions and considering factors like pediatric dosing, formulations, administration routes, potential complications, and USP guidelines. The document outlines supplies and procedures for compounding a pediatric special dilution, including anteroom and clean room preparation steps.
Pulmonary drug delivery (PDD) systems were recently introduced into the pharmaceutical field to treat both the local and the systemic types of lung diseases. PDD systems are known to be able to simply deliver the drug to the required site in the body directly or to other distant sites through the bloodstream.
The document provides an overview of drug delivery to the respiratory system. It discusses the advantages of pulmonary drug delivery such as it being needle-free and requiring a low dose. It describes the different regions of the respiratory tract and various formulation approaches for drug delivery, including marketed products that use different devices like dry powder inhalers and metered dose inhalers. The document also mentions some patented preparations and recent advances in pulmonary drug delivery.
3 Dimensional Printing is a fast prototyping or improver manufacturing is a fresh advanced skill that making 3D shapes in a layer by layer method straight by computer aided drug design technology. 3D printing has a high-class chance for the grounding of personalized medication to patient wants. In 3D printing sequential layers of material are shaped under computer control to create an object. It is consuming high degree of elasticity over controls over the release of drug which is formulated as in different layers of tablets. This review highlight with advantages, disadvantages, types, principle, steps involved, challenges and applications of 3D printing in Pharmaceutical.
This document provides an overview of extemporaneous preparations, which are medications created on-site to meet specific patient needs. It defines extemporaneous preparations and outlines their purpose. The document lists common pediatric extemporaneous preparations and provides an example of creating a frusemide suspension. It also reviews guidelines for oral liquid pediatric preparations and concludes with references. Risks of extemporaneous preparations include effects on stability, dosing errors, contamination, and acceptability. Careful formulation, documentation, and monitoring are important.
Nasal drug delivery is a method of administering drugs through the nose for local or systemic effects. It avoids first-pass metabolism and provides rapid drug absorption. Liquid nasal formulations like solutions, suspensions, and sprays are most common. Powders can also be used with insufflators or dry powder inhalers. Various animal models are used to evaluate nasal absorption and bioavailability. Nasal delivery enhances drug bioavailability for molecules that are not well-absorbed orally.
This document provides an overview of orodispersible tablets. It discusses their history, formulation strategies, evaluation parameters and benefits over conventional tablets. Orodispersible tablets are designed to dissolve rapidly in the mouth without water. They were developed to help patients like children, elderly and those with swallowing difficulties. The key ingredients are superdisintegrants which cause the tablet to break apart quickly. Evaluation tests include hardness, friability, wetting time and in vitro dissolution studies. Orodispersible tablets offer ease of administration, accurate dosing and enhanced bioavailability compared to other dosage forms.
computer aided formulation and development(How to use design expert software)Roshan Bodhe
computer aided formulation and development
optimization in formulation and development
How to use design expert software in formulation and development
Introduction to pulmonary drug delivery system,pressurized meter dose inhaller(pMDI),Meter dose inhaller(MDI),Dry powder inhaller(DPI), Advantages of PDDS
This document discusses total parenteral nutrition (TPN). It provides learning objectives about TPN preparation and administration. It introduces TPN as nutrition administered to patients who cannot absorb nutrients normally. It describes the types of parenteral nutrition as peripheral and total parenteral nutrition. It discusses indications for prescribing TPN, formulation of TPN solutions, guidelines for ordering TPN, and risks associated with TPN preparation.
Formulation factors affecting drug absorptionDiwakar Chudal
This document discusses how excipients and other formulation factors can influence drug absorption. It explains that excipients are added to ensure stability, uniformity, and optimal bioavailability. However, excipients can also impact absorption based on their type and amount. Factors like vehicle, diluents, binders, disintegrants and others are described in terms of how they can increase or decrease the rate of drug absorption from different dosage forms. The document emphasizes that proper selection of excipients and dosage form is important to maximize a drug's bioavailability.
This document discusses nasal drug delivery and provides an overview of the anatomy and physiology of the nasal cavity, mechanisms of nasal absorption, factors affecting nasal drug absorption, evaluation methods, and marketed nasal preparations. It describes the nasal cavity's potential for achieving rapid systemic drug absorption while avoiding first-pass metabolism. Various dosage forms for nasal delivery including liquids, powders, gels, and sprays are presented along with strategies to improve nasal absorption and residence time.
This document discusses aquasomes, which are nanoparticulate drug delivery systems composed of a ceramic core coated with polyhydroxy oligomers. It describes how aquasomes are prepared through a simple process involving the preparation of a ceramic core, coating it with carbohydrates, and immobilizing drug molecules. The document evaluates various properties of the ceramic core, sugar coating, and drug-loaded aquasomes. Aquasomes offer advantages like increased drug efficacy and avoidance of multiple injections. They have applications in oxygen carrying, immunotherapy, and delivery of drugs, enzymes, insulin, and vaccines.
The main idea is the incompatibilities that accrue between the IV drug with drug, solution, container and IV set .
Simple study of incompatibilities of drug admixtures in Iraq , that accrue heavily in pharmacy and hospitals, it incorrect because the compliance of patient not a reason for admixture and we didn't found any study on this admixtures that confirm it safety. At last it very important to avoid it because the great risk .
NIOSOMES , GENERAL CHARACTERISTICS OF NIOSOME , TYPES OF NIOSOMES , OTHERS TYPES OF NIOSOMES , NIOSOMES VS LIPOSOMES , COMPONENTS OF NIOSOMES , Non-ionic surfactant , Cholesterol , Charge inducing molecule , METHOD OF PREPARATION , preparation of small unilamellar vesicles , Sonication , Micro fluidization , preparation of large unilamellar vesicles , Reverse Phase Evaporation , Ether Injection , preparation of Multilamellar vesicles , Hand shaking method , Trans membrane pH gradient drug uptake process (remote loading) , Miscellaneous method :Multiple membrane extrusion method , The “Bubble” Method , Formation of Niosomes From Proniosomes , SEPARATION OF UNENTRAPPED DRUGS , Gel Filtration , Dialysis , Centrifugation , FACTORS AFFECTING THE PHYSICOCHEMICAL PROPERTIES OF NIOSOMES , Membrane Additives , Temperature of Hydration , PROPERTIES OF DRUGS , AMOUNT AND TYPE OF SURFACTANT
Structure of Surfactants , Resistance to Osmotic Stress , Characterization of niosomes ,Therapeutic applications of Niosomes , For Controlled Release of Drugs , To Improve the Stability and Physical Properties of the Drugs , For Targeting and Retention of Drug in Blood Circulation , Proniosomes , Aspasomes , Vesicles in Water and Oil System (v/w/o) ,Bola - niosomes , Discomes , Deformable niosomes or elastic niosomes , According to the nature of lamellarity ,Small Unilamellar vesicles (SUV) 25 – 500 nm in size.,Large Unilamellar vesicles (LUV) 0.1 – 1μm in size , Multilamellar vesicles (MLV) 1-5 μm in size , According to the size:Small Niosomes (100 nm – 200 nm) , Large Niosomes (800 nm – 900 nm),Big Niosomes (2 μm – 4 μm)
This document discusses suppositories, including:
- Suppositories are solid dosage forms meant to be inserted into body cavities like the rectum, vagina, urethra, nose, and ear to release drugs locally or systemically.
- They are classified based on the cavity they are meant for, like rectal, vaginal, urethral, nasal, and ear suppositories.
- Ideal suppository bases melt at body temperature, are non-toxic, chemically inert, and compatible with drugs. Common bases include fatty bases like cocoa butter and emulsifying bases like Witepsol.
- Suppositories have advantages like easy administration and avoidance of first-pass metabolism, but also disadvantages
This document provides an overview of nanogels including their classification, properties, synthesis methods, and applications. It discusses how nanogels are nanosized hydrogel particles formed by crosslinking hydrophilic polymers. They can be stimuli-responsive or non-responsive. Methods for synthesizing nanogels include photolithography, membrane emulsification, chemical crosslinking, and polymerization. Nanogels show potential for drug and gene delivery in applications such as cancer treatment, wound healing, and more due to their biocompatibility and ability to encapsulate and release therapeutic agents.
targeted drug delivery system to respiratory systemAnusha Golla
The document presents information on targeting drugs to the lungs for pulmonary drug delivery. It begins with an introduction and overview of lung anatomy. It then discusses the advantages and disadvantages of pulmonary drug delivery, mechanisms of particle deposition in the airways, and various systems used to target the lungs including microspheres, liposomes, nanoparticles, and dendrimers. The document provides details on different dosage forms for pulmonary delivery such as metered dose inhalers, dry powder inhalers, and nebulizers. It concludes with examples of marketed pulmonary drug products.
artificial intelligence in Pharmacy field.pptxpriyranjan8
In this we have discussed about importance of Artificial intelligence in healthcare and especially in pharmacy fields. How technology is upgrading the pharmacy field. And in future it's impact.
This document discusses polymer membrane permeation controlled drug delivery systems. It defines controlled release as delivering drugs at predetermined rates over long periods from a single dose. Controlled release implies predictable and reproducible drug release kinetics. A key example is a system where a drug reservoir is covered by a rate-controlling polymeric membrane. The membrane thickness and drug properties determine the release rate. Applications include the Norplant implant and Ocusert ocular insert.
This document discusses nasal drug delivery systems. It begins with an overview of nasal drug delivery and its advantages, including rapid drug absorption and avoidance of first-pass metabolism. It then covers various aspects of nasal delivery such as dosage forms, factors affecting drug absorption, formulation considerations, and applications. A case study is also presented on the development of a zolmitriptan nasal gel for the treatment of migraines. In under 3 sentences:
Nasal drug delivery provides a non-invasive alternative to oral and injectable routes, allowing for rapid systemic drug absorption while avoiding first-pass metabolism, and various dosage forms and formulation strategies can be used to enhance drug delivery and absorption through the nasal mucosa for local and systemic treatment
The document discusses various drug delivery systems for nasal administration including liquid nasal formulations, powder dosage forms, nasal gels and others. It describes the composition, preparation and evaluation of these nasal formulations. Some key delivery systems discussed are nasal drops, sprays, dry powder inhalers and metered dose inhalers. The document also outlines animal models and in vitro methods used to evaluate nasal absorption and permeation of drugs. Currently marketed nasal formulations containing xylometazoline and azelastine are also mentioned.
This document provides an overview of ampule-based preparations for sterile compounding. It defines what ampules are and how they are designed to break open at the neck. It outlines the safety procedures that must be followed when opening ampules, such as using a filter needle to remove any glass fragments. The document discusses the types of medications found in ampules and how they are administered. It also reviews the risks associated with parenteral preparations and ampule-based preparations specifically. Finally, it provides guidance on following USP Chapter <797> guidelines and understanding the necessary resources and supplies for working with ampules.
This document provides an overview of topics related to medication orders and labeling. It discusses the historical roots of prescriptions and medical terminology. The document outlines learning objectives and topics that will be covered, including medication orders, types of orders, order contents and processing, sterile compound labeling, and medical abbreviations. It provides introductory information on orders, root words, and signa language used for writing orders.
3 Dimensional Printing is a fast prototyping or improver manufacturing is a fresh advanced skill that making 3D shapes in a layer by layer method straight by computer aided drug design technology. 3D printing has a high-class chance for the grounding of personalized medication to patient wants. In 3D printing sequential layers of material are shaped under computer control to create an object. It is consuming high degree of elasticity over controls over the release of drug which is formulated as in different layers of tablets. This review highlight with advantages, disadvantages, types, principle, steps involved, challenges and applications of 3D printing in Pharmaceutical.
This document provides an overview of extemporaneous preparations, which are medications created on-site to meet specific patient needs. It defines extemporaneous preparations and outlines their purpose. The document lists common pediatric extemporaneous preparations and provides an example of creating a frusemide suspension. It also reviews guidelines for oral liquid pediatric preparations and concludes with references. Risks of extemporaneous preparations include effects on stability, dosing errors, contamination, and acceptability. Careful formulation, documentation, and monitoring are important.
Nasal drug delivery is a method of administering drugs through the nose for local or systemic effects. It avoids first-pass metabolism and provides rapid drug absorption. Liquid nasal formulations like solutions, suspensions, and sprays are most common. Powders can also be used with insufflators or dry powder inhalers. Various animal models are used to evaluate nasal absorption and bioavailability. Nasal delivery enhances drug bioavailability for molecules that are not well-absorbed orally.
This document provides an overview of orodispersible tablets. It discusses their history, formulation strategies, evaluation parameters and benefits over conventional tablets. Orodispersible tablets are designed to dissolve rapidly in the mouth without water. They were developed to help patients like children, elderly and those with swallowing difficulties. The key ingredients are superdisintegrants which cause the tablet to break apart quickly. Evaluation tests include hardness, friability, wetting time and in vitro dissolution studies. Orodispersible tablets offer ease of administration, accurate dosing and enhanced bioavailability compared to other dosage forms.
computer aided formulation and development(How to use design expert software)Roshan Bodhe
computer aided formulation and development
optimization in formulation and development
How to use design expert software in formulation and development
Introduction to pulmonary drug delivery system,pressurized meter dose inhaller(pMDI),Meter dose inhaller(MDI),Dry powder inhaller(DPI), Advantages of PDDS
This document discusses total parenteral nutrition (TPN). It provides learning objectives about TPN preparation and administration. It introduces TPN as nutrition administered to patients who cannot absorb nutrients normally. It describes the types of parenteral nutrition as peripheral and total parenteral nutrition. It discusses indications for prescribing TPN, formulation of TPN solutions, guidelines for ordering TPN, and risks associated with TPN preparation.
Formulation factors affecting drug absorptionDiwakar Chudal
This document discusses how excipients and other formulation factors can influence drug absorption. It explains that excipients are added to ensure stability, uniformity, and optimal bioavailability. However, excipients can also impact absorption based on their type and amount. Factors like vehicle, diluents, binders, disintegrants and others are described in terms of how they can increase or decrease the rate of drug absorption from different dosage forms. The document emphasizes that proper selection of excipients and dosage form is important to maximize a drug's bioavailability.
This document discusses nasal drug delivery and provides an overview of the anatomy and physiology of the nasal cavity, mechanisms of nasal absorption, factors affecting nasal drug absorption, evaluation methods, and marketed nasal preparations. It describes the nasal cavity's potential for achieving rapid systemic drug absorption while avoiding first-pass metabolism. Various dosage forms for nasal delivery including liquids, powders, gels, and sprays are presented along with strategies to improve nasal absorption and residence time.
This document discusses aquasomes, which are nanoparticulate drug delivery systems composed of a ceramic core coated with polyhydroxy oligomers. It describes how aquasomes are prepared through a simple process involving the preparation of a ceramic core, coating it with carbohydrates, and immobilizing drug molecules. The document evaluates various properties of the ceramic core, sugar coating, and drug-loaded aquasomes. Aquasomes offer advantages like increased drug efficacy and avoidance of multiple injections. They have applications in oxygen carrying, immunotherapy, and delivery of drugs, enzymes, insulin, and vaccines.
The main idea is the incompatibilities that accrue between the IV drug with drug, solution, container and IV set .
Simple study of incompatibilities of drug admixtures in Iraq , that accrue heavily in pharmacy and hospitals, it incorrect because the compliance of patient not a reason for admixture and we didn't found any study on this admixtures that confirm it safety. At last it very important to avoid it because the great risk .
NIOSOMES , GENERAL CHARACTERISTICS OF NIOSOME , TYPES OF NIOSOMES , OTHERS TYPES OF NIOSOMES , NIOSOMES VS LIPOSOMES , COMPONENTS OF NIOSOMES , Non-ionic surfactant , Cholesterol , Charge inducing molecule , METHOD OF PREPARATION , preparation of small unilamellar vesicles , Sonication , Micro fluidization , preparation of large unilamellar vesicles , Reverse Phase Evaporation , Ether Injection , preparation of Multilamellar vesicles , Hand shaking method , Trans membrane pH gradient drug uptake process (remote loading) , Miscellaneous method :Multiple membrane extrusion method , The “Bubble” Method , Formation of Niosomes From Proniosomes , SEPARATION OF UNENTRAPPED DRUGS , Gel Filtration , Dialysis , Centrifugation , FACTORS AFFECTING THE PHYSICOCHEMICAL PROPERTIES OF NIOSOMES , Membrane Additives , Temperature of Hydration , PROPERTIES OF DRUGS , AMOUNT AND TYPE OF SURFACTANT
Structure of Surfactants , Resistance to Osmotic Stress , Characterization of niosomes ,Therapeutic applications of Niosomes , For Controlled Release of Drugs , To Improve the Stability and Physical Properties of the Drugs , For Targeting and Retention of Drug in Blood Circulation , Proniosomes , Aspasomes , Vesicles in Water and Oil System (v/w/o) ,Bola - niosomes , Discomes , Deformable niosomes or elastic niosomes , According to the nature of lamellarity ,Small Unilamellar vesicles (SUV) 25 – 500 nm in size.,Large Unilamellar vesicles (LUV) 0.1 – 1μm in size , Multilamellar vesicles (MLV) 1-5 μm in size , According to the size:Small Niosomes (100 nm – 200 nm) , Large Niosomes (800 nm – 900 nm),Big Niosomes (2 μm – 4 μm)
This document discusses suppositories, including:
- Suppositories are solid dosage forms meant to be inserted into body cavities like the rectum, vagina, urethra, nose, and ear to release drugs locally or systemically.
- They are classified based on the cavity they are meant for, like rectal, vaginal, urethral, nasal, and ear suppositories.
- Ideal suppository bases melt at body temperature, are non-toxic, chemically inert, and compatible with drugs. Common bases include fatty bases like cocoa butter and emulsifying bases like Witepsol.
- Suppositories have advantages like easy administration and avoidance of first-pass metabolism, but also disadvantages
This document provides an overview of nanogels including their classification, properties, synthesis methods, and applications. It discusses how nanogels are nanosized hydrogel particles formed by crosslinking hydrophilic polymers. They can be stimuli-responsive or non-responsive. Methods for synthesizing nanogels include photolithography, membrane emulsification, chemical crosslinking, and polymerization. Nanogels show potential for drug and gene delivery in applications such as cancer treatment, wound healing, and more due to their biocompatibility and ability to encapsulate and release therapeutic agents.
targeted drug delivery system to respiratory systemAnusha Golla
The document presents information on targeting drugs to the lungs for pulmonary drug delivery. It begins with an introduction and overview of lung anatomy. It then discusses the advantages and disadvantages of pulmonary drug delivery, mechanisms of particle deposition in the airways, and various systems used to target the lungs including microspheres, liposomes, nanoparticles, and dendrimers. The document provides details on different dosage forms for pulmonary delivery such as metered dose inhalers, dry powder inhalers, and nebulizers. It concludes with examples of marketed pulmonary drug products.
artificial intelligence in Pharmacy field.pptxpriyranjan8
In this we have discussed about importance of Artificial intelligence in healthcare and especially in pharmacy fields. How technology is upgrading the pharmacy field. And in future it's impact.
This document discusses polymer membrane permeation controlled drug delivery systems. It defines controlled release as delivering drugs at predetermined rates over long periods from a single dose. Controlled release implies predictable and reproducible drug release kinetics. A key example is a system where a drug reservoir is covered by a rate-controlling polymeric membrane. The membrane thickness and drug properties determine the release rate. Applications include the Norplant implant and Ocusert ocular insert.
This document discusses nasal drug delivery systems. It begins with an overview of nasal drug delivery and its advantages, including rapid drug absorption and avoidance of first-pass metabolism. It then covers various aspects of nasal delivery such as dosage forms, factors affecting drug absorption, formulation considerations, and applications. A case study is also presented on the development of a zolmitriptan nasal gel for the treatment of migraines. In under 3 sentences:
Nasal drug delivery provides a non-invasive alternative to oral and injectable routes, allowing for rapid systemic drug absorption while avoiding first-pass metabolism, and various dosage forms and formulation strategies can be used to enhance drug delivery and absorption through the nasal mucosa for local and systemic treatment
The document discusses various drug delivery systems for nasal administration including liquid nasal formulations, powder dosage forms, nasal gels and others. It describes the composition, preparation and evaluation of these nasal formulations. Some key delivery systems discussed are nasal drops, sprays, dry powder inhalers and metered dose inhalers. The document also outlines animal models and in vitro methods used to evaluate nasal absorption and permeation of drugs. Currently marketed nasal formulations containing xylometazoline and azelastine are also mentioned.
This document provides an overview of ampule-based preparations for sterile compounding. It defines what ampules are and how they are designed to break open at the neck. It outlines the safety procedures that must be followed when opening ampules, such as using a filter needle to remove any glass fragments. The document discusses the types of medications found in ampules and how they are administered. It also reviews the risks associated with parenteral preparations and ampule-based preparations specifically. Finally, it provides guidance on following USP Chapter <797> guidelines and understanding the necessary resources and supplies for working with ampules.
This document provides an overview of topics related to medication orders and labeling. It discusses the historical roots of prescriptions and medical terminology. The document outlines learning objectives and topics that will be covered, including medication orders, types of orders, order contents and processing, sterile compound labeling, and medical abbreviations. It provides introductory information on orders, root words, and signa language used for writing orders.
Cleaning the Horizontal Laminar Flow Hood Kdurant36
The document provides instructions for cleaning a horizontal laminar airflow hood according to USP Chapter <797> guidelines. It describes the various components of the horizontal hood and their functions in maintaining sterility. It outlines the necessary supplies, including sterile water, sterile 70% isopropyl alcohol, and lint-free wipes. It also provides a preview of the cleaning procedure, which involves first using sterile water to remove any residue, followed by sterile 70% isopropyl alcohol as the primary disinfectant. Upon completion, the technician must document the cleaning on the hood-cleaning checklist.
Aseptic Garbing, Hand Washing, and Gloving Kdurant36
The document provides an overview of aseptic garbing, hand washing, and gloving procedures according to USP Chapter <797> guidelines. It discusses learning objectives, topics that will be covered, and the importance of maintaining asepsis when preparing sterile compounded products. Specific procedures covered include self-assessment, use of personal protective equipment like gowns and gloves, essential supplies, and designated areas for aseptic hand washing. The goal is to avoid introducing pathogens while protecting both patients and healthcare workers.
This document provides an overview of chemotherapy products and procedures. It discusses the historical use of chemotherapy to treat cancer and identifies special considerations for preparing chemotherapy. Key topics covered include common chemotherapy drug categories, properties and compounding of chemotherapy CSPs, handling risks, training requirements, administration procedures, and USP Chapter <797> guidelines for chemotherapy preparation. The learning objectives, resources, and lab procedure are also previewed.
This document discusses various supplies used for sterile compounding, including needles, syringes, IV bags, vials, and ampules. It describes the components and proper use of these supplies, emphasizing that critical sites must be touched only with sterile tools to avoid contamination. Most sterile compounding procedures use a regular needle that is 1 1/2 inches long and syringes to withdraw or inject solutions.
This document discusses large-volume parenteral preparations, which are intravenous solutions administered to patients to maintain fluid balance. It covers the physiology of fluid balance in the body, properties parenteral products must have like pH and osmolarity, and potential complications of parenteral therapy like infection. The learning objectives are to understand fluid balance, parenteral product characteristics, risks of therapy, and how to properly prepare and administer large-volume parenteral preparations according to USP guidelines.
Cleaning and Disinfecting iv Hoods and RoomsJerry Fahrni
There are plenty of rules regarding when and how pharmacy iv rooms should be cleaned and disinfected. This presentation gives a basic overview of those rules as found in USP Chapter <797>
Basic principles of compounding and dispensing (Prescription) MANIKImran Nur Manik
Weight, measure and units calculation for compounding and dispensing. Fundamental operation in compounding. Good pharmaceutical practices in compounding and dispensing. Containers and closures for dispensed products. Responding to prescription, labeling of dispensed medications.
The document discusses the history and development of parenteral nutrition, which began in the 1960s with lipid infusions and the development of parenteral nutrition for patients who had lost their small bowel. It then covers key aspects of parenteral nutrition including formulations, administration routes, indications, and complications. Total parenteral nutrition provides complete nutritional support through intravenous infusion and is indicated when enteral nutrition is not feasible or sufficient, such as in cases of severe gastrointestinal dysfunction.
- An assessment of chemical health risks was conducted at the pharmacy department of Hospital X on May 28, 2019.
- The assessment evaluated 4 chemicals - denatured ethyl alcohol 96%, acetic acid, hydrogen peroxide 34%, and undenatured ethanol 96% - and found they posed medium to high risks. However, existing control measures were deemed adequate for all chemicals.
- The report provided recommendations to further improve controls, such as additional PPE, improved labeling, training, and establishing medical surveillance if exposure monitoring levels are exceeded.
The document outlines various policies and procedures related to pharmacy services in a hospital setting. It discusses requirements for 24-hour pharmacy operations or on-call pharmacist coverage. It also addresses stocking of emergency drug supplies, preparation of parenteral nutrition solutions, documentation of medication errors, and legal and ethical principles governing pharmacy practice.
The document discusses adverse drug reaction (ADR) reporting tools. It provides a brief history of pharmacovigilance and describes the ADR reporting process from healthcare professionals to regional and zonal centers, and finally to national and global databases. It emphasizes the importance of post-marketing ADR monitoring to identify uncommon or rare reactions not detected during clinical trials. Key aspects like what information to report, who can report, and how to submit reports using standardized forms are summarized. Common ADR reporting software tools like Argus are also highlighted.
1. This document summarizes guidelines for conducting stability studies on drug products and substances according to ICH recommendations. It discusses factors that affect drug stability like temperature, humidity and light. 2. The guidelines describe long term, accelerated and intermediate testing conditions specified by ICH for different climate zones. They also provide examples of accelerated stability testing methods for formulations like emulsions, suspensions and tablets. 3. The document stresses the importance of summarizing stability study results and proposing a shelf life and storage conditions based on the data collected over time.
Mohammad Nur Sharif presented on impurities in drug substances. The objectives were to make recommendations to applicants on reporting, identifying, qualifying, and providing source information on impurities in new drug substances. Impurities can come from raw materials, reagents, manufacturing processes, atmospheric contamination, defects in processes, and intermediate products. Thresholds for reporting, identifying, and qualifying impurities were provided based on maximum daily dose.
This document outlines objectives and provides information on food safety management systems, active managerial control, the FDA's public health interventions, HACCP principles, specialized food processing requiring a variance, crisis management, responding to a foodborne illness outbreak, and responding to imminent health hazards. It defines key terms, identifies the seven HACCP principles, and provides examples of how to apply HACCP and respond to different crisis situations regarding food safety.
Standardization of Excipients by Shubham WakdeShubham Wakde
This document discusses the standardization process for new excipients. It outlines the need to verify the intended use and properties of a new excipient. The standardization process involves evaluating the excipient's chemical and physical properties, impurity profile, and functionality. It also requires preclinical testing to establish the excipient's safety profile. International guidelines provide recommendations for the types of studies required for oral, topical, parenteral, and other routes of administration. Proper documentation of an excipient's characterization and specifications in monographs helps ensure consistent quality between batches.
This document summarizes guidelines for stability testing of biological and biotechnological products according to ICH guidelines. It discusses factors that affect stability, types of stability testing, storage conditions, and testing frequency. The key points are that stability testing must demonstrate a product's identity, purity, and potency remain within specified limits during its proposed shelf life under various storage conditions, and that testing should include real-time studies and may involve accelerated or stress conditions to establish an expiration date.
The document discusses pharmacovigilance and adverse drug reactions (ADRs). It provides historical context on important events that increased focus on pharmacovigilance like the Thalidomide disaster. It describes the need for pharmacovigilance due to limitations of preclinical and clinical trials. It outlines the aims, methods like spontaneous reporting and causality assessment, and programs in India and by the WHO. It defines ADRs and provides classifications. In summary, the document overviews the importance and process of pharmacovigilance in monitoring drug safety post marketing.
This document outlines patient safety goals and standards. It defines key terms like risk and safety. It lists international patient safety goals such as identifying patients correctly and reducing healthcare associated infections. National patient safety goals are discussed in more detail and include accurately identifying patients, improving caregiver communication, safely using medications, reducing anticoagulant therapy harm, maintaining accurate medication information, reducing clinical alarm hazards, and preventing healthcare associated infections. The document provides specific requirements for implementing several of the national goals.
The document discusses regulatory requirements and procedures for approval of new vaccines in India. It provides definitions of key terms like drugs, new drugs and vaccines. It describes the information and data required to be submitted for approval, including safety and efficacy data from clinical trials. It also discusses post-marketing surveillance requirements and procedures for investigating and reporting adverse events following immunization.
The document provides guidelines for developing a food safety programme or risk management programme for ice cream production. It outlines the purpose and scope of the guidelines, as well as instructions for using the guidelines to develop a programme. The guidelines include information on HACCP principles, components required in a programme, and supporting systems related to processes, premises, facilities, equipment, people, services, and other programme activities. The document is intended to help ice cream manufacturers design, implement, operate and maintain a food safety programme.
The document presents an overview of ICH guidelines. It discusses that ICH was created in 1990 to harmonize pharmaceutical regulations between Europe, Japan, and the US. ICH has developed over 45 guidelines divided into quality, safety, efficacy, and multidisciplinary categories. The quality guidelines address chemical and pharmaceutical quality assurance. The safety guidelines cover preclinical safety testing. The efficacy guidelines relate to clinical trial design, conduct, and reporting. The multidisciplinary guidelines cover topics that do not fit uniquely into the other categories. In summary, the document provides a high-level introduction to the structure and guidelines of the International Council for Harmonisation.
ADR Reporting Exercises for Undergraduate studentsPharmacolvigilance practs.pptxSURAJ PANCHAL
This document discusses adverse drug reactions (ADRs), including defining ADRs, differentiating them from adverse drug events, classifying types and severity of ADRs. It describes pharmacovigilance programs and processes for detecting, reporting, and assessing ADRs using tools like Naranjo's algorithm or WHO causality categories. The importance of ADR reporting to national and international centers is explained to help prevent future occurrences.
Capnography: Discover Patient Safety Secrets Right Under Your NoseChristina Mason
This document discusses the importance and benefits of capnography monitoring in healthcare. Capnography provides immediate and accurate information about a patient's ventilation status and response to interventions in a noninvasive way. It can be used for patients of all ages and in many clinical situations, such as procedural sedation, opioid administration, assessing ventilation during cardiac arrest or CPR, and guiding ventilator management. The document recommends capnography monitoring as it can help detect complications early, guide treatment, and improve patient outcomes and safety.
The ICH guidelines define the stability testing requirements for new drug registrations to harmonize the process across the US, EU, and Japan. Stability testing provides data on a drug's quality over time under different conditions to determine proper storage and establish a shelf life. The guidelines specify conducting real-time and accelerated testing of multiple batches using validated methods to evaluate degradation and set acceptance criteria ensuring patient safety.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
3. Topics3
Learning Objectives
Gain an awareness of the history of narcotic medications.
Understand the legal regulations and procedures that must be
followed when preparing various controlled substances for
parenteral administration.
Identify the USP Chapter <797> procedures that must be
performed when preparing narcotic compounded sterile
preparations (CSPs).
Demonstrate correct technique in the preparation of narcotic
CSPs.
2012 Paradigm Publishing
4. Topics4
Topics
Learning Objectives
Introduction
Drug Schedules
Properties of Narcotic CSPs
Potential Complications of Parenteral Therapy
Controlled Substance Storage
Controlled Substance Record Keeping
Patient-Controlled Analgesia
USP Chapter <797> Guidelines for Controlled
Substance CSPs
Understand the Resources and Supplies
Preview the Lab Procedure
Chapter Summary
2012 Paradigm Publishing
In Slide Show view, click
the desired topic to the
left to link directly to the
related slide. To return
to this slide at any point
in the presentation, click
the Topics button below.
5. Topics55
Introduction
The CSA classifies
controlled substances
according to their
potential for abuse and
addiction
most narcotic CSPs
prepared by IV
technicians are
comprised of a C–II
narcotic mixed with a
base solution
2012 Paradigm Publishing
6. Topics66
Drug Schedules
The CSA organizes controlled
substances into five drug schedules
or classes based on their potential
for abuse and addiction
in addition to these federal
regulations enforced by the DEA, each
individual State Board of Pharmacy
provides guidelines and oversight
regarding the prescribing and
dispensing of controlled substances
2012 Paradigm Publishing
9. Topics99
Drug Schedules…/4
Community or retail pharmacies often stock C–III
through C–V medications on the shelf along with
noncontrolled substance medications
in this type of environment, C–II controlled substances
must be tracked using a perpetual inventory system
Most institutional or hospital pharmacies store all
classes of controlled substances under a double-lock
system
2012 Paradigm Publishing
10. Topics1010
Properties of Narcotic CSPs
The physical and chemical properties of narcotic
medications vary widely
most narcotics have chemical properties that are generally
isotonic, isoosmotic, and pH neutral
occasionally, narcotics have an acidic pH value or are
hypertonic or hyperosmotic
in those instances, the narcotic must be injected into an IV
or IVPB base solution; the resulting CSP has physical and
chemical properties that are generally isotonic, isoosmotic,
and pH neutral
2012 Paradigm Publishing
11. Topics1111
Potential Complications of
Parenteral Therapy
All patients receiving parenteral therapy should be
monitored for the following complications:
nosocomial infection
allergic reaction (including anaphylaxis)
phlebitis
tissuing
embolism
extravasation
cellulitis
Stevens-Johnson syndrome
nephrotoxicity
2012 Paradigm Publishing
12. Topics1212
Potential Complications of
Parenteral Therapy…/2
Patients with end-stage cancer or other terminal
diseases sometimes build up a narcotic tolerance to
the narcotic medications used to control their pain
the IV technician may be required to prepare an LVP
preparation by injecting a C–II narcotic, such as
hydromorphone or morphine into an IV base solution
In the hospital, hospice, or home healthcare setting,
nursing personnel typically administer the
compounded preparation to the patient
2012 Paradigm Publishing
13. Topics1313
Potential Complications of
Parenteral Therapy…/3
Patients receiving high-
dose narcotics face a
heightened risk from
central nervous system
(CNS) depression
must be closely monitored
to prevent a potentially
fatal reduction in their
respiratory or cardiac
functions
2012 Paradigm Publishing
14. Topics1414
Controlled Substance Storage
Controlled substances carry various levels of risk with
regard to their potential for drug abuse and
controlled substance diversion, or narcotic diversion
proper controlled substance storage is essential in
mitigating these risks
2012 Paradigm Publishing
15. Topics1515
Controlled Substance Storage…/2
In the institutional setting,
all controlled substances
within the pharmacy are
kept in the narcotic room
under a double-lock system
2012 Paradigm Publishing
16. Topics16
Your Turn
2012 Paradigm Publishing
1) Most narcotic CSPs prepared by IV technicians are comprised of this
narcotic mixed with a base solution.
a. C–I
b. C–II
c. C–III
d. C–IV
2) Most institutional or hospital pharmacies store all classes of
controlled substances under this system.
a. no-lock
b. single-lock
c. double-lock
d. triple-lock
In Slide Show view,
click here to see
the answer to
Question 1. Then
click again to
advance to
Question 2.
In Slide Show view,
click here to see
the answer to
Question 2.
17. Topics1717
Controlled Substance Record
Keeping
Proper controlled substance
record keeping is also critical
for reducing the possibility of
drug abuse and controlled
substance diversion
there is one aspect of controlled
substance record keeping that
all sterile compounding
personnel should know: the use
of a perpetual inventory record
2012 Paradigm Publishing
18. Topics1818
Controlled Substance Record
Keeping…/2
Perpetual Inventory Log Book
The perpetual inventory log book is an official, legal
record with pages titled “Perpetual Inventory
Record” or “Controlled Substance Record”
is kept in the narcotic room or vault and is a record of all
activity relating to the medications in the narcotic room
2012 Paradigm Publishing
20. Topics2020
Controlled Substance Record
Keeping…/4
Perpetual Inventory Log Book…continued
Every controlled substance that leaves the narcotic
room—for example, to fill floor stock, prepare an
epidural cassette, or compound a PCA syringe—must
be signed out and subtracted from the perpetual
inventory record
this process is referred to as a narcotic sign-out, or a
controlled substance sign-out
2012 Paradigm Publishing
22. Topics2222
Controlled Substance Record
Keeping…/6
Error Correction in the Perpetual Inventory Log Book
In most facilities, pharmacy personnel will record an
entry or addition to the log in black ink, and record
withdrawals or negative balances in red ink
personnel should never erase, scribble over, or use
correcting tape or fluid to cover transcription errors
instead, technicians should note an error by drawing a
single line through the entire entry and placing their
circled initials next to the text with the strike-through line
2012 Paradigm Publishing
23. Topics2323
Controlled Substance Record
Keeping…/7
Security and Disposal of Controlled Substances
To provide the utmost security, sterile compounding
personnel should always ensure that the narcotics,
the keys to the narcotic room, and all narcotic
records are kept in their control
if a discrepancy is discovered while creating a record in the
perpetual inventory log book, IV technicians must
immediately report it to their instructor or pharmacist
2012 Paradigm Publishing
24. Topics2424
Controlled Substance Record
Keeping…/8
Security and Disposal of Controlled
Substances…continued
IV technicians must also properly dispose of unused
controlled substance solutions after completing
sterile compounding procedures
In order to prevent narcotic diversion, all narcotic
waste procedures must be recorded in the perpetual
inventory record and must be observed by a narcotic
waste witness
2012 Paradigm Publishing
25. Topics2525
Patient-Controlled Analgesia
IV technicians need to be
familiar with several
different controlled
substance CSPs and their
preparation, including
LVPs used for chronic,
severe pain control as
well as epidurals and
patient-controlled
analgesia (PCA)
2012 Paradigm Publishing
26. Topics2626
Patient-Controlled Analgesia…/2
A PCA provides narcotic pain control, or narcotic
analgesia, for hospitalized patients
allows a patient to self-administer a dose of the
medication intravenously by pressing a handheld
controller
is preprogrammed to lock out the patient if a dose is
requested before the scheduled time
experience has shown that patient control of analgesia
leads to less narcotic use and, therefore, less potential for
issues related to drug tolerance or side effects
2012 Paradigm Publishing
27. Topics2727
USP Chapter <797> Guidelines
for Controlled Substance CSPs
In addition to the detailed record-keeping mandates
for controlled substances, there are a number of
other procedures that must be carefully followed
while compounding controlled substance
preparations
these procedures are presented in USP Chapter <797> and
are reinforced in each facility’s P&P manual
sterile compounding personnel must pay strict attention to
aseptic protocols both in the anteroom and clean room
2012 Paradigm Publishing
28. Topics2828
Understand the Resources and
Supplies
Essential Supplies
Most sterile compounding procedures require the
same essential supply items to be available for use in
both the anteroom and the clean room
2012 Paradigm Publishing
29. Topics2929
Understand the Resources and
Supplies…/2
Procedure-Specific Supplies
Controlled-Substance
Perpetual Inventory
Log Book
PCA Supply Items
a Luer-to-Luer connector is
a small plastic device used
to join the tips of two
syringes
2012 Paradigm Publishing
30. Topics3030
Understand the Resources and
Supplies…/3
Procedure-Specific
Supplies…continued
PCA Supply Items…continued
need to attach a sterile, plastic
cap, called a syringe cap, to the
tip of the PCA syringe
an IVA syringe seal is an
adhesive seal that is often
affixed to a syringe cap to
provide evidence of tampering
2012 Paradigm Publishing
31. Topics3131
Understand the Resources and
Supplies…/4
Procedure-Specific Supplies…continued
IVPB Base Solutions
the same type of bag used for other vial-based IVPBs: a
bag with a tail injection port
insert the needle directly into the injection port of an IVPB
without regard to the position of the needle bevel and
without creating any bend to the needle
2012 Paradigm Publishing
32. Topics3232
Understand the Resources and
Supplies…/5
Critical Sites of Essential Supplies and PCA Supplies
Before beginning preparatory procedures in the
anteroom or clean room, the IV technician must
recall the critical sites of the supplies
identifying the critical site of each supply item helps you to
determine the proper procedure for handling the supply
item once you enter the clean room and begin working in
the hood
2012 Paradigm Publishing
33. Topics3333
Preview the Lab Procedure
Anteroom Preparatory
Procedures
verifying the CSP label against the
medication order
performing correct pharmacy
calculations to determine type, size,
and number of supply items needed
gathering and cleaning of supplies
performing aseptic garbing and
hand washing
donning a sterile gown
2012 Paradigm Publishing
34. Topics3434
Preview the Lab Procedure…/2
Clean Room Preparatory Procedures
when preparing controlled substance preparations for
patient administration, sterile compounding personnel
must diligently follow established pharmacy clean room
protocols as well
once the preparatory steps have been completed, narcotic
PCA syringe compounding procedures may begin
2012 Paradigm Publishing
35. Topics3535
Preview the Lab Procedure…/3
Narcotic PCA Syringe
Compounding Procedure
after the verification check,
aseptically remove the
needle from the narcotic
syringe and carefully attach
one end of a Luer-to-Luer
connector to the tip of the
filled narcotic syringe
2012 Paradigm Publishing
36. Topics36
Your Turn
2012 Paradigm Publishing
3) This log book is an official, legal record.
a. perpetual account
b. perpetual stash
c. perpetual inventory
d. perpetual stock
4) This is often affixed to a syringe cap to provide evidence of tampering.
a. IVA syringe capsule
b. IVA syringe tube
c. IVA syringe seal
d. IVA syringe cap
In Slide Show view,
click here to see
the answer to
Question 3. Then
click again to
advance to
Question 4.
In Slide Show view,
click here to see
the answer to
Question 4.